EUVIMEDEUVIMED entdecken
Open Access

Prediction of impaired lung diffusion capacity in COVID-19 pneumonia survivors

Olga I Savushkina iD, Elena S Muraveva iD, Irina V Zhitareva iD, Galina V Nekludova iD, Malika Kh Mustafina iD, Sergey N Avdeev iD

Journal of Thoracic Disease · 2024-11 · 16 (11) · 7282-7289

DOI: 10.21037/jtd-24-1118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thoracic Disease, 2024-11. Verfasst von Olga I Savushkina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Research Institute under Federal Medical and Biological Agency of Russia, Moscow, Russia. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients surviving the coronavirus disease 2019 (COVID-19) are reported to explore pulmonary sequelae. It is challenging to provide pulmonary function tests (PFTs) during the pandemic of this contagious diseases because of the difficulty related to infection control risks. This study aims to identify important predictors of lung diffusion capacity impairment in COVID-19 survivors after hospital discharge.

Methods

The retrospective cohort study included 341 patients after COVID-19. The parameters of spirometry, body plethysmography, lung diffusion capacity for carbon monoxide (DLco), and the worst chest computed tomography (CT) scan in the acute phase of COVID-19 (CTmax, %) were assessed. Multivariable logistic regression analysis for exploring risk factors associated with lung diffusion capacity impairment was used. The receiver operating characteristic (ROC) curve of multivariate observation and the area under the curve (AUC) were used to assess the performance of a model.

Results

At the time of the analysis, 64.8% (221/341) patients participated in follow-up visits on 90 days, 23.5% (80/341) on 90-180 days, and 11.7% (40/341) on more than 180 days after the onset of COVID-19 symptoms. The median CTmax was 50% (50% of the lung area was involved in a pathological process according to a semi-quantitative CT score). Abnormal DLco (

Schlagwörter

Stichwörter der Autor:innen

Pulmonary functional testsabnormal diffusion capacity predictorspost-coronavirus disease 2019 (post-COVID-19)

Autor:innen und Institutionen

  • Pulmonology Research Institute under Federal Medical and Biological Agency of Russia, Moscow, Russia.
  • Pirogov Russian National Research Medical University (Pirogov Medical University), Moscow, Russia.
  • Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

ORCID-Profile: Olga I Savushkina, Elena S Muraveva, Irina V Zhitareva, Galina V Nekludova, Malika Kh Mustafina, Sergey N Avdeev

Zitieren

APA

Savushkina, O. I., Muraveva, E. S., Zhitareva, I. V., Nekludova, G. V., Mustafina, M. K., & Avdeev, S. N. (2024). Prediction of impaired lung diffusion capacity in COVID-19 pneumonia survivors. Journal of Thoracic Disease, 16(11), 7282-7289. https://doi.org/10.21037/jtd-24-1118

Vancouver

Savushkina OI, Muraveva ES, Zhitareva IV, Nekludova GV, Mustafina MK, Avdeev SN. Prediction of impaired lung diffusion capacity in COVID-19 pneumonia survivors. Journal of Thoracic Disease. 2024;16(11):7282-7289. doi:10.21037/jtd-24-1118

BibTeX
@article{Savushkina2024,
  author = {Savushkina, Olga I and Muraveva, Elena S and Zhitareva, Irina V and Nekludova, Galina V and Mustafina, Malika Kh and Avdeev, Sergey N},
  title = {Prediction of impaired lung diffusion capacity in COVID-19 pneumonia survivors},
  journal = {Journal of Thoracic Disease},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {7282--7289},
  doi = {10.21037/jtd-24-1118}
}
Kostenlos starten →